Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Sutro Biopharma (STRO) Income towards Parent Company (2017 - 2025)

Historic Income towards Parent Company for Sutro Biopharma (STRO) over the last 9 years, with Q3 2025 value amounting to -$56.9 million.

  • Sutro Biopharma's Income towards Parent Company fell 1654.13% to -$56.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$206.2 million, marking a year-over-year decrease of 6631.12%. This contributed to the annual value of -$227.5 million for FY2024, which is 11301.11% down from last year.
  • Per Sutro Biopharma's latest filing, its Income towards Parent Company stood at -$56.9 million for Q3 2025, which was down 1654.13% from -$11.5 million recorded in Q2 2025.
  • Sutro Biopharma's 5-year Income towards Parent Company high stood at $31.1 million for Q4 2023, and its period low was -$72.5 million during Q4 2024.
  • Over the past 5 years, Sutro Biopharma's median Income towards Parent Company value was -$38.5 million (recorded in 2023), while the average stood at -$35.9 million.
  • As far as peak fluctuations go, Sutro Biopharma's Income towards Parent Company surged by 18977.57% in 2023, and later crashed by 33337.73% in 2024.
  • Over the past 5 years, Sutro Biopharma's Income towards Parent Company (Quarter) stood at -$38.1 million in 2021, then increased by 9.26% to -$34.6 million in 2022, then surged by 189.78% to $31.1 million in 2023, then tumbled by 333.38% to -$72.5 million in 2024, then grew by 21.55% to -$56.9 million in 2025.
  • Its Income towards Parent Company stands at -$56.9 million for Q3 2025, versus -$11.5 million for Q2 2025 and -$65.3 million for Q1 2025.